We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLK icon
3876
Westlake Corp
WLK
$9.46B
-88,325
Closed -$10.9M
WLY icon
3877
John Wiley & Sons Class A
WLY
$2.52B
-17,983
Closed -$954K
WPC icon
3878
W.P. Carey
WPC
$17.1B
-8,450
Closed -$669K
WSM icon
3879
Williams-Sonoma
WSM
$26.7B
-146,120
Closed -$10.6M
WWW icon
3880
Wolverine World Wide
WWW
$1.54B
-23,497
Closed -$530K
X
3881
CALL
DELISTED
US Steel
X
-200
Closed -$8K
X
3882
PUT
DELISTED
US Steel
X
-28,800
Closed -$1.09M
XAR icon
3883
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.07B
-3,046
Closed -$379K
XFOR icon
3884
X4 Pharmaceuticals
XFOR
$363M
-437
Closed -$23K
XLB icon
3885
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
-59,976
Closed -$2.64M
XLE icon
3886
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
-103,600
Closed -$3.96M
XLC icon
3887
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
-62,707
Closed -$4.31M
XLI icon
3888
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
-3,100
Closed -$317K
XLI icon
3889
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
-17,700
Closed -$1.82M
XLK icon
3890
PUT
State Street Technology Select Sector SPDR ETF
XLK
$115B
-6,000
Closed -$477K
XLRE icon
3891
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
-12,342
Closed -$597K
XLV icon
3892
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
-6,200
Closed -$849K
XNCR icon
3893
Xencor
XNCR
$1.44B
-206,292
Closed -$5.5M
XOM icon
3894
CALL
ExxonMobil
XOM
$651B
-78,100
Closed -$6.45M
XOM icon
3895
ExxonMobil
XOM
$651B
-475,115
Closed -$39.2M
XOM icon
3896
PUT
ExxonMobil
XOM
$651B
-175,700
Closed -$14.5M
XP icon
3897
XP
XP
$8.62B
-267,973
Closed -$8.07M
XXII
3898
22nd Century Group
XXII
$1.47M
0
-$1.17M
XWEL icon
3899
XWELL
XWEL
$8.87M
-3,682
Closed -$83K
YJ
3900
Yunji
YJ
$6.55M
-3,378
Closed -$139K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.